Consequently, GIP and GLP-1 receptor agonists exhibit complementary and potentially synergistic actions, suggesting that their combined administration may further enhance glucose regulation and support weight reduction.1113,50 This rationale underpins the development of dual GLP-1/GIP receptor agonists, which have been proposed as super-GLP-1 receptor agonists because of GIPs capacity of GIP to potentiate GLP-1 effects.48,51 Clinical Pharmacology of GLP-1RAs The incretin effect of GLP-1RAs was initially characterized by the observation that oral glucose administration elicits a proportionally greater and more sustained insulin secretion compared to an equivalent intravenous glucose dose.52,53 This incretin effect, which accounts for approximately two-thirds of the total insulin secretion during an oral glucose tolerance test, is diminished in individuals with T2DM
What Is Ozempic and How Do GLP-1 Medications Work
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
[1] Dulaglutide (Trulicity): 0.75 mg or 1.5 mg once weekly for type 2 diabetes
Ingredients: Rated 9/10 Clean and plant-based
No single foodor combination of foodscan replicate the potency or duration of GLP-1 medications